CLINICAL_TRIALS
trial_result
· 2007-10-30
Clinical Trial Update: Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension [Phase 2]
Summary
Phase IIa safety and efficacy study of SPP635 for mild to moderate hypertension has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Speedel Pharma Ltd. | Conditions: Hypertension | Phase 2 | Status: COMPLETED